X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Lancet Respiratory Medicine

期刊標題檢索 LANCET RESP MED 最新評論: Simply read the abstract and conclusion to determine how much of your ... (2021-12-30)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Lancet Respiratory Medicine]您好,您是該頁面的第 30640 位訪客。

期刊簡介
期刊名稱Lancet Respiratory Medicine Lancet Respiratory Medicine
LetPub Score
9.4
50 ratings
Rate

Reputation
10.0

Influence
9.3

Speed
7.0

期刊簡稱LANCET RESP MED
ISSN2213-2600
E-ISSN2213-2619
h-index79
CiteScore
CiteScoreSJRSNIPCiteScore Rank
87.107.9658.252
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Pulmonary and Respiratory Medicine
Q11 / 155

自引率 (2023-2024)1.80%自引率趨勢
掲載範囲
The Lancet Respiratory Medicine delivers comprehensive, clinically-focused coverage on all areas of respiratory medicine and critical care, including but not limited to: COPD, asthma, cystic fibrosis, IPF, pneumonia, influenza, tuberculosis, sarcoidosis, pulmonary hypertension, sleep medicine, respiratory infections, pulmonary vascular disease, lung cancer, tobacco control, thoracic and reconstructive surgery, mesothelioma, and palliative medicine. Continuing in The Lancet's tradition of publishing high-impact content that influences medical practice, each monthly issue of The Lancet Respiratory Medicine contains Original Research, Reviews, Personal Views, Comments, and News.

The Lancet Respiratory Medicine is stringently edited and peer-reviewed to ensure the scientific merit and clinical relevance of its diverse content. Original Research is fast-tracked to publication within 8 weeks of submission (on average) and published Online First on www.thelancet.com before appearing in print.

Now indexed in PubMed, Journal Citation Reports®, and Scopus, the journal accepts submissions of Original Research, Reviews, Personal Views, and Comments. Visit http://ees.elsevier.com/thelancetrm to learn more about our editorial scope and aims and to submit your manuscript.

Gold or Green Open Access is available for research supported by selected funding agencies with whom Elsevier has an agreement. The journal is also freely available to readers in low-to-middle-income countries via the HINARI programme or via IP access at www.thelancet.com.

To find out more about The Lancet Respiratory Medicine, visit www.thelancet.com/respiratory.
官方網站http://www.thelancet.com/journals/lanres/onlinefirst
在線稿件提交https://www.editorialmanager.com/THELANCETRM
開放訪問No
出版商Elsevier Ltd
主題領域RESPIRATORY SYSTEM
出版國/地區ENGLAND
發行頻率
創刊年0
每年文章數62每年文章數趨勢
黃金OA百分比32.20%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CRITICAL CARE MEDICINESCIEQ11/54
RESPIRATORY SYSTEMSCIEQ11/100
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2213-2600%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據:
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Lancet Respiratory Medicine】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Journal of Breath ResearchH-index: 45

    CiteScore: 7.60
    npj Primary Care Respiratory MedicineH-index: 16

    CiteScore: 5.50
    Thoracic CancerH-index: 20

    CiteScore: 5.20
    Annals of Thoracic MedicineH-index: 29

    CiteScore: 4.10
    Primary Care Respiratory JournalH-index: 44

    CiteScore: 0.00
    學科內最受檢索的期刊 頁面查看次數
    Thoracic Cancer65780
    Journal of Breath Research20566
    Annals of Thoracic Medicine13644
    npj Primary Care Respiratory Medicine12743
    Primary Care Respiratory Journal8765
  •  

    Lancet Respiratory Medicine Lancet Respiratory Medicine
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Lancet Respiratory Medicine] 的評論撰寫評論
作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 18:49:41 評論於
Simply read the abstract and conclusion to determine how much of your content has already been published. Organize and submit to journals with lower Impact Factors than those already published as soon as possible
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 09:51:45 評論於
The model diagram can clearly and directly display the overall idea of the article
(0) 讚! | 维尔娜菲茨杰拉德

作者: 北国博达


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 12:16:46 評論於
What should I do if the experimental data were published ahead of time?
(0) 讚! | 北国博达

作者: 八坂篷蔚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 10:19:48 評論於
Is the use of a model figure conducive or detrimental to reviewers' attitudes towards manuscripts?
(0) 讚! | 八坂篷蔚

作者: 诗双小郎君


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-06-01 10:23:47 評論於
Review speed: 1.0 | Submission success rate: 5.0
Experience sharing: Real-time 19.05, final must break 20 points
(0) 讚! | 诗双小郎君

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-16 16:00:05 評論於
Who can predict how many points there will be next year?
(0) 讚! | 凌霄高洁

作者: 法慧和同


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-06-19 14:39:53 評論於
Review Speed: 3.0 | Submission Success Rate: 50.0
Sharing Experience: Make a move and sweep away the traditional classics, the future is limitless
(0) 讚! | 法慧和同

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Lancet Respiratory Medicine] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*